These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16986263)

  • 41. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Removing obstacles in neuroscience drug discovery: the future path for animal models.
    Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
    Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase 0 trials: an industry perspective.
    Eliopoulos H; Giranda V; Carr R; Tiehen R; Leahy T; Gordon G
    Clin Cancer Res; 2008 Jun; 14(12):3683-8. PubMed ID: 18559583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled insulin products puff along.
    Powell K
    Nat Biotechnol; 2004 Oct; 22(10):1195-6. PubMed ID: 15470441
    [No Abstract]   [Full Text] [Related]  

  • 45. Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury.
    Dellinger RP; Vincent JL; Marshall J; Reinhart K
    J Crit Care; 2008 Dec; 23(4):493-9. PubMed ID: 19056012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimizing the preclinical/clinical interface: an Informa Life Sciences conference 12-13 December, 2006, London, UK.
    Cavero I
    Expert Opin Drug Saf; 2007 Mar; 6(2):217-24. PubMed ID: 17367268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New insights into drug development for pediatric solid tumors: what preclinical data justify clinical trials in pediatric cancer?
    Houghton PJ
    Expert Rev Anticancer Ther; 2013 Oct; 13(10):1135-8. PubMed ID: 24093514
    [No Abstract]   [Full Text] [Related]  

  • 48. Preclinical dose number and its application in understanding drug absorption risk and formulation design for preclinical species.
    Wuelfing WP; Daublain P; Kesisoglou F; Templeton A; McGregor C
    Mol Pharm; 2015 Apr; 12(4):1031-9. PubMed ID: 25671350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacometrics 2020.
    Gobburu JV
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):151S-157S. PubMed ID: 20881229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The need for modeling and simulation to design clinical investigations in children.
    Jadhav PR; Kern SE
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):121S-129S. PubMed ID: 20881225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002).
    Rowland M; Balant L; Peck C
    AAPS PharmSci; 2004 Feb; 6(1):E6. PubMed ID: 15198507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translational research: 4 ways to fix the clinical trial.
    Ledford H
    Nature; 2011 Sep; 477(7366):526-8. PubMed ID: 21956311
    [No Abstract]   [Full Text] [Related]  

  • 53. A semiparametric model for regression analysis of interval-censored failure time data.
    Finkelstein DM; Wolfe RA
    Biometrics; 1985 Dec; 41(4):933-45. PubMed ID: 3830259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of preclinical animal models in breast cancer drug development.
    Clarke R
    Breast Cancer Res; 2009; 11 Suppl 3(Suppl 3):S22. PubMed ID: 20030874
    [No Abstract]   [Full Text] [Related]  

  • 55. The challenges of translational research for analgesics: the state of knowledge needs upgrading and some uncomfortable deficiencies remain to be urgently addressed.
    Quessy SN
    J Pain; 2010 Jul; 11(7):698-700. PubMed ID: 20605748
    [No Abstract]   [Full Text] [Related]  

  • 56. Monitoring versus interim analysis of clinical trials: a perspective from the pharmaceutical industry.
    Enas GG; Dornseif BE; Sampson CB; Rockhold FW; Wuu J
    Control Clin Trials; 1989 Mar; 10(1):57-70. PubMed ID: 2702837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Biological trials of chemical compounds: the strategy of the initial search].
    Piruzian LA; Landau MA
    Izv Akad Nauk SSSR Biol; 1989; (1):42-9. PubMed ID: 2715494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Connecting the dots: role of standardization and technology sharing in biological simulation.
    Ghosh S; Matsuoka Y; Kitano H
    Drug Discov Today; 2010 Dec; 15(23-24):1024-31. PubMed ID: 20934535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modelling of the blood-brain barrier in drug discovery and development.
    Cecchelli R; Berezowski V; Lundquist S; Culot M; Renftel M; Dehouck MP; Fenart L
    Nat Rev Drug Discov; 2007 Aug; 6(8):650-61. PubMed ID: 17667956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.